# Ginkgo Bioworks Holdings, Inc. (DNA)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/DNA/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 39.63M | $ -129.30M | $ -95.51M | $ 404.11M | $ 420.28M |
| 2025 | $ 174.22M | $ -320.24M | $ -198.68M | $ 439.89M | $ 508.59M |
| 2024 | $ 238.64M | $ -574.97M | $ -401.64M | $ 467.73M | $ 716.06M |
| 2023 | $ 271.89M | $ -965.42M | $ -363.63M | $ 239.31M | $ 1.10B |
| 2022 | $ 533.65M | $ -2.35B | $ -340.12M | $ 442.59M | $ 1.74B |
| 2021 | $ 373.04M | $ -2.18B | $ -368.89M | $ 23.03M | $ 1.51B |
| 2020 | $ 97.66M | $ -161.29M | $ -246.70M | $ 17.00M | $ 461.38M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.96 |
| Liabilities / Eq | 1.36 |
| Current Ratio | 4.57 |

## Other views

- [Metrics](https://sponda.capital/en/DNA.md)
- [Charts](https://sponda.capital/en/DNA/charts.md)
- [Compare](https://sponda.capital/en/DNA/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.
